Tinea Versicolor
📧 Sign up to get email alerts when something new happens for Tinea Versicolor.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-11-19Clinical Trial Update: A Study of the Clinical Efficacy and Safety of 20% Cassia Alata Extract Against Tinea Versicolor [Phase 1]
Phase 1 clinical trial evaluating the efficacy and safety of 20% Cassia alata extract for treating Tinea versicolor; the study is currently …
-
CLINICAL_TRIALS trial_result · 2025-07-03Clinical Trial Update: A Trial to Evaluate the Safety and Antimicrobial Efficacy of DBI-002 Probiotic in Adults With Tinea Versicolor [Phase 2]
Phase 2 trial evaluating the safety and antimicrobial efficacy of DBI-002 Probiotic in adults with tinea versicolor has completed and posted…
-
FDA approval · 2022-03-04FDA Approved: NYSTATIN AND TRIAMCINOLONE ACETONIDE — Original Application (Alembic Pharmaceuticals Inc.)
FDA approved an Original Application for a generic Nystatin and Triamcinolone Acetonide topical product from Alembic Pharmaceuticals Inc.
-
FDA approval · 2021-05-21FDA Approved: KETOCONAZOLE — Original Application (Xiromed, LLC)
FDA has approved Xiromed, LLC's original generic application for Ketoconazole Foam, a topical antifungal 2% product.
-
FDA approval · 2020-02-18FDA Approved: KETOCONAZOLE — Supplemental Application (THIRTY MADISON INC)
The FDA approved a supplemental application for Ketoconazole filed by Thirty Madison Inc, resulting in updates to the Ketoconazole product l…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2019-10-01Clinical Trial Update: Clinical Assessment of Voriconazole Self Nano Emulsifying Drug Delivery System Intermediate Gel [Phase 2]
Phase 2 clinical trial assessing voriconazole self nano emulsifying drug delivery system intermediate gel for tinea versicolor has completed…
-
CLINICAL_TRIALS trial_result · 2019-10-01Clinical Trial Update: Clinical Assessment of Itraconazole Self Nano Emulsifying Drug Delivery System Intermediate Gel [Phase 2]
Phase 2 clinical trial assessing itraconazole self nano emulsifying drug delivery system intermediate gel for tinea versicolor has completed…
-
FDA approval · 2018-06-18FDA Approved: KETOCONAZOLE — Original Application (Strides Pharma Science Limited)
FDA approved Strides Pharma Science Limited's original ANDA for Ketoconazole, a generic antifungal product, covering common dermatophytic an…
-
FDA approval · 2016-02-25FDA Approved: CICLOPIROX OLAMINE — Supplemental Application (Glenmark Pharmaceuticals Inc., USA)
FDA approved a supplemental application for Ciclopirox olamine to update labeling and support use for common superficial fungal skin infecti…
-
FDA approval · 2015-08-31FDA Approved: KETOCONAZOLE — Supplemental Application (THIRTY MADISON INC)
FDA approved a supplemental application for Ketoconazole from Thirty Madison Inc under an existing ANDA, signaling an approved modification …
-
FDA approval · 2015-08-19FDA Approved: OXISTAT — Supplemental Application (ANI Pharmaceuticals, Inc.)
FDA approved a supplemental application for Oxistat (oxiconazole nitrate) from ANI Pharmaceuticals, Inc.
-
FDA approval · 2013-05-21FDA Approved: CICLOPIROX OLAMINE — Supplemental Application (Cosette Pharmaceuticals, Inc.)
FDA approved a supplemental application for Ciclopirox Olamine from Cosette Pharmaceuticals, resulting in updated labeling for its topical a…
-
FDA approval · 2013-01-03FDA Approved: KETOCONAZOLE — Supplemental Application (THIRTY MADISON INC)
FDA approves a supplemental application for ketoconazole submitted by Thirty Madison Inc (ANDA076942).
-
CLINICAL_TRIALS trial_result · 2012-08-22Clinical Trial Update: Ketoconazole Foam 2% for the Treatment of Versicolor [Phase 4]
A Phase 4 trial evaluating ketoconazole foam 2% for tinea versicolor has completed with results posted.
-
FDA approval · 2012-02-29FDA Approved: CICLOPIROX — Original Application (Glenmark Pharmaceuticals Inc., USA)
FDA approved Glenmark's ciclopirox as a generic product under an original ANDA application.
-
FDA approval · 2011-08-25FDA Approved: KETOCONAZOLE — Original Application (Padagis Israel Pharmaceuticals Ltd)
FDA approved Padagis Israel Pharmaceuticals Ltd's Ketoconazole original application (ANDA 091550) for a generic ketoconazole product.
-
FDA approval · 2010-09-17FDA Approved: NIZORAL — Supplemental Application (Kramer Laboratories)
FDA approved a supplemental application for NIZORAL (ketoconazole) from Kramer Laboratories, resulting in labeling updates for the product.
-
FDA approval · 2010-02-16FDA Approved: CICLOPIROX — Original Application (Padagis Israel Pharmaceuticals Ltd)
The FDA approved Padagis Israel Pharmaceuticals Ltd's Ciclopirox topical product under Original Application (ANDA 078594), authorizing its m…
-
FDA approval · 2010-02-12FDA Approved: LAMISIL AT — Supplemental Application (Karo Healthcare Inc.)
FDA approved a supplemental application for LAMISIL AT (terbinafine hydrochloride) from Karo Healthcare Inc. under NDA 021124. This action u…
-
FDA approval · 2009-11-24FDA Approved: CICLOPIROX — Original Application (Actavis Pharma, Inc.)
FDA approves Ciclopirox as a generic topical antifungal product under an original application from Actavis Pharma, Inc.
-
FDA approval · 2009-03-18FDA Approved: KETOCONAZOLE — Supplemental Application (E. Fougera & Co. a division of Fougera Pharmaceuticals, LLC)
FDA approved a supplemental ANDA for Ketoconazole, a generic antifungal product from E. Fougera & Co. (division of Fougera Pharmaceuticals).
-
FDA approval · 2007-09-18FDA Approved: CICLOPIROX — Original Application (Chartwell RX, LLC)
FDA granted approval of the original ANDA for ciclopirox from Chartwell RX, LLC, enabling the marketing of a ciclopirox topical antifungal p…
-
FDA approval · 2007-09-18FDA Approved: CICLOPIROX — Original Application (Padagis Israel Pharmaceuticals Ltd)
The FDA approved Ciclopirox as a generic drug under ANDA 077623 from Padagis Israel Pharmaceuticals Ltd.